Doctors test radiation 'Paint' to shrink tumors before prostate removal
NCT ID NCT07208240
Summary
This trial is testing a new targeted radiation treatment (called Tb-PSMA) given to men with high-risk prostate cancer before they have surgery to remove the prostate. The goal is to see if this pre-surgery treatment is safe and if it helps surgeons remove more of the cancer, reducing the chance it will come back. The study will enroll 20 men to carefully monitor safety and early signs of effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH RISK PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beilinson Hospital
RECRUITINGPetah Tikva, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.